Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset INMD
Coverage 165,865 Raw stories ingested 21,788 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 Live Pipeline agents
  • FMP Stock News Fetch every minute running now
  • FMP Forex News Fetch every 5 min 2m ago
  • CoinGecko News Fetch every 5 min 4m ago
  • FIO Stock News Fetch every 10 min 7m ago
  • Patria Stock News Fetch every 10 min 7m ago
  • Editorial rewrite Rewrite every minute 1m ago
  • Asset sync Assets every 1 hour 26m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Clear
Details Date Content Source Relevance
2026-09-09 13:48 2h ago
2026-09-09 08:05 7h ago
InMode představuje Morpheus8 Cool pro pohodlnější RF microneedling
INMD InMode
FMP Stock News 78
Original source text
, /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announces the launch of Morpheus8 Cool, the next evolution of its renowned Morpheus8 technology. Available exclusively on the new expandable Morpheus8MAX platform, Morpheus8 Cool advances radiofrequency (RF) microneedling with enhanced comfort, precision, control, and safety.

Recognized as the world's #1 RF microneedling procedure, Morpheus8 is establishing a new industry standard with Morpheus8 Cool. The new handpiece and large-surface cooling tip feature game-changing Cool Comfort Technology, intelligently managing the thermal profile to elevate the treatment experience.  Morpheus8 Cool also features a new interactive user interface for enhanced control and safety.  Practitioners can select Guided Mode, with preset, clinically effective parameters that support consistent, repeatable outcomes, or Manual Mode for fully customizable settings.

"Developed in response to feedback from our providers, Guided Mode within the Morpheus8MAX platform offers greater versatility across their practices," said Dr. Michael Kreindel, InMode Chief Technology Officer and co-founder. "Its intuitive design gives practitioners greater flexibility to tailor treatments to each patient's skin concerns and anatomy while delivering the remarkable results patients and providers have come to expect from Morpheus8."

"Morpheus8 Cool addresses an important challenge in aesthetics: how to make a proven, successful technology even better," said Dr. Eran Krieger, Chief Medical Officer at InMode. "By cooling the skin's surface while treating the targeted tissue, we preserve the remodeling effect without compromising treatment. We are not changing the treatment—we are elevating the patient experience."

"The excitement surrounding Morpheus8 Cool was undeniable when we introduced it at our Insider Summit in Las Vegas," said Michael Dennison, InMode President, North America. "Providers immediately recognized the value of greater comfort, precision, and control, and the enthusiastic response reinforced the strong demand for this next evolution of Morpheus8 technology."

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Press Contact:
Behrman Cesa Communications
[email protected]

Investor Contact:
MS-IR LLC
Miri Segal – Scharia
[email protected]

SOURCE InMode Ltd.
2026-08-05 12:20 1mo ago
2026-08-05 07:00 1mo ago
InMode: Tržby stagnují, čistý zisk výrazně klesl
INMD InMode
FMP Stock News 92
Original source text
, /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter of 2026.

Second Quarter 2026 Highlights:

Quarterly GAAP revenues of $95.6 million, consistent with the second quarter of 2025. Quarterly revenues from consumables and service of $22.3 million, an increase of 13% compared to the second quarter of 2025. GAAP operating income of $12.3 million and *non-GAAP operating income of $16.0 million. Total cash position of $501.1 million as of June 30, 2026, including cash and cash equivalents, marketable securities and short-term bank deposits. Completed the repurchase of 6.38 million ordinary shares for an aggregate purchase price of $87.8 million through the previously announced share repurchase program. U.S. GAAP Results

                                          (U.S. dollars in thousands, except for per share data)                                          

Q2 2026

Q2 2025

$95,589

$95,602

75 %

80 %

13 %

24 %

$17,064

$26,742

$0.29

$0.42

*Non-GAAP Results

(U.S. dollars in thousands, except for per share data)

Q2 2026

Q2 2025

75 %

80 %

17 %

28 %

$20,812

$30,139

$0.35

$0.47

*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements included in this release. Non-GAAP results exclude share-based compensation, expenses related to independent transaction committee review (representing non-recurring cost) and related income tax adjustments where applicable.

Management Comments

"Overall revenue was consistent with the prior-year period, and we saw continued stability in our U.S. capital equipment business, reflecting steady customer demand. This performance is consistent with the stabilization we anticipate will continue through the remainder of the year. We remain focused on investing in opportunities that support long-term growth," said Moshik Itzkovich, Chief Financial Officer of InMode.

Second Quarter 2026 Financial Results

Total GAAP revenues for the second quarter of 2026 were $95.6 million, consistent with the second quarter of 2025. Revenue from Asia reached a quarterly record, reflecting continued strength across key markets in the region. Quarterly revenues from consumables and service grew 13% compared to the second quarter of 2025, to $22.3 million, derived primarily from international sales.

GAAP gross margin for the second quarter of 2026 was 75%, compared to 80% for the second quarter of 2025.

*Non-GAAP gross margin for the second quarter of 2026 was 75%, compared to 80% for the second quarter of 2025.

GAAP operating margin for the second quarter of 2026 was 13%, compared to 24% for the second quarter of 2025. *Non-GAAP operating margin for the second quarter of 2026 was 17%, compared to 28% for the second quarter of 2025. These decreases were primarily attributable to higher cost of goods sold, product mix, the restructuring of the North America sales team implemented toward the end of 2025, additional marketing and sales investments to retain talent and maintain market share, and higher general and administrative expenses driven by increased professional services costs. We expect these trends to continue for the foreseeable future.

InMode reported GAAP net income of $17.1 million, or $0.29 per diluted share, in the second quarter of 2026, compared to $26.7 million, or $0.42 per diluted share, in the second quarter of 2025. On a *non-GAAP basis, InMode reported net income of $20.8 million, or $0.35 per diluted share, in the second quarter of 2026, compared to $30.1 million, or $0.47 per diluted share, in the second quarter of 2025.

As of June 30, 2026, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $501.1 million.

Appointed New Chief Financial Officer and New Board Director 

On May 20, 2026, the Company announced the appointment of Dr. Shlomo Nass as its new Chairman of the Company's Board of Directors, effective May 19, 2026. The Company also announced the appointment of Moshe (Moshik) Itzkovich as the Company's new Chief Financial Officer, effective May 19, 2026, while former Chief Financial Officer Yair Malca continues to be engaged with the Company as a consultant.

2026 Financial Outlook

Management provided an outlook for the full fiscal year ending December 31, 2026. Based on current estimates, management expects:

Revenues between $365 million and $375 million *Non-GAAP gross margin between 74% and 76% *Non-GAAP income from operations to be between $68 million and $73 million *Non-GAAP earnings per diluted share between $1.29 and $1.34 However, these expectations are based on management's current estimates, which may be updated.

This outlook is not a guarantee of future performance, and shareholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.

*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation, expenses related to independent transaction committee review (representing non-recurring cost) and related income tax adjustments where applicable.

Conference Call and Webcast Update

As previously announced, while the Company's Special Committee continues its evaluation of unsolicited proposals, the Company will not host an investor conference call or webcast in connection with this earnings release and will not be conducting investor meetings at this time.

The Current Situation in Israel

The scope and severity of ongoing conflicts in Gaza, Northern Israel, Lebanon, Iran, and the broader region are unpredictable and could escalate at any time. To date, our operations have not been materially affected. We continue to monitor political and military developments closely and examine the consequences for our operations and assets. 

Use of Non-GAAP Financial Measures

In addition to InMode's operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin, non-GAAP gross margin and non-GAAP income from operations. Because these measures are used in InMode's internal analysis of financial and operating performance, management believes they provide investors with greater transparency into its view of InMode's economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode's GAAP operating results, allows investors to more effectively evaluate and compare InMode's performance to that of its peers, although InMode's presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release. Reconciliations of non-GAAP gross margin, non-GAAP income from operations, and non-GAAP earnings per diluted share for management's projections of such non-GAAP financials for the 2026 fiscal year are not available without unreasonable effort due to the variability, complexity and limited visibility of certain reconciling items. These reconciling items could have a significant and unpredictable impact on our future GAAP results.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements 

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Company Contact:
Moshik Itzkovich
Chief Financial Officer
Email: [email protected] 

Investor Relations Contact:
Miri Segal
MS-IR LLC
Email: [email protected] 

INMODE LTD.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(U.S. dollars in thousands, except for per share data)

(Unaudited)

Three months ended

Six months ended

June 30,

June 30,

2026

2025

2026

2025

REVENUES

95,589

95,602

177,606

173,476

COST OF REVENUES

24,073

19,152

44,538

36,115

GROSS PROFIT

71,516

76,450

133,068

137,361

OPERATING EXPENSES:

Research and development

3,656

3,372

7,198

6,267

Sales and marketing

50,818

47,474

93,750

87,201

General and administrative

4,785

2,723

9,807

5,394

TOTAL OPERATING EXPENSES                                                

59,259

53,569

110,755

98,862

OPERATING INCOME

12,257

22,881

22,313

38,499

Finance income, net

7,432

8,062

11,728

14,921

INCOME BEFORE INCOME TAXES

19,689

30,943

34,041

53,420

INCOME TAXES

2,625

4,201

5,415

8,477

NET INCOME

17,064

26,742

28,626

44,943

EARNINGS PER SHARE:

Basic

0.29

0.42

0.47

0.68

Diluted

0.29

0.42

0.46

0.68

WEIGHTED AVERAGE NUMBER

OF SHARES OUTSTANDING USED

IN COMPUTATION OF EARNINGS

PER SHARE (in thousands)

Basic

58,903

63,252

61,140

65,982

Diluted

59,378

63,637

61,717

66,540

INMODE LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands, except for per share data)

(Unaudited)

June 30,

2026

December 31,

2025

Assets

CURRENT ASSETS:

Cash and cash equivalents

396,173

302,543

Marketable securities

18,995

83,632

Short-term bank deposits

85,947

169,159

Accounts receivable, net of allowance for credit losses

44,555

43,504

Prepaid expenses and other receivables

32,664

25,733

Inventories

71,661

74,050

         TOTAL CURRENT ASSETS                                                                                 

649,995

698,621

    NON-CURRENT ASSETS:

Accounts receivable, net of allowance for credit losses

5,686

3,005

Deferred income tax assets

52,629

53,230

Operating lease right-of-use assets

8,693

8,274

Property and equipment, net

2,628

2,599

Other investments

700

700

TOTAL NON-CURRENT ASSETS

70,336

67,808

TOTAL ASSETS

720,331

766,429

Liabilities and shareholders' equity

CURRENT LIABILITIES:

Accounts payables

18,792

17,912

Contract liabilities

15,452

12,093

Other liabilities

45,193

40,739

TOTAL CURRENT LIABILITIES

79,437

70,744

    NON-CURRENT LIABILITIES:

Contract liabilities

2,484

3,043

Other liabilities

4,825

4,436

Operating lease liabilities

4,451

5,008

TOTAL NON-CURRENT LIABILITIES

11,760

12,487

TOTAL LIABILITIES

91,197

83,231

TOTAL SHAREHOLDERS' EQUITY

629,134

683,198

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

720,331

766,429

INMODE LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands, except for per share data)

(Unaudited)

Three months ended
June 30,

Six months ended
June 30,

2026

2025

2026

2025

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income

17,064

26,742

28,626

44,943

Adjustments required to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

179

191

354

365

Share-based compensation expenses

3,708

3,418

6,407

5,936

Change in allowance for credit losses of trade receivable

719

147

1,244

53

Loss on marketable securities, net



5



3

Finance expenses (income), net

388

(313)

1,107

(1,887)

Deferred income taxes

295

566

622

1,462

Changes in operating assets and liabilities:

Decrease (increase) in accounts receivable (current and non-current)

(5,046)

(3,285)

(4,974)

1,259

Decrease (increase) in other receivables

(1,164)

1,276

(7,030)

(2,256)

Decrease (increase) in inventories

(253)

(4,329)

2,389

(8,562)

Increase in accounts payable

1,939

2,430

880

3,700

Increase (decrease) in other liabilities (current and non-current)

4,400

127

4,012

(3,160)

Increase (decrease) in contract liabilities (current and non-current)

(1,178)

(2,903)

2,800

(3,740)

Net cash provided by operating activities

21,051

24,072

36,437

38,116

CASH FLOWS FROM INVESTING ACTIVITIES:

   Investment in short-term deposits

(85,000)

(25,000)

(169,912)

(25,000)

   Proceeds from short-term deposits

84,912

55,000

252,570

86,297

   Purchase of fixed assets

(211)

(219)

(383)

(304)

   Purchase of marketable securities



-

(9,727)

(20,877)

   Proceeds from sale of marketable securities



-



3,003

   Proceeds from maturity of marketable securities

37,983

41,875

74,239

104,022

Net cash provided by investing activities

37,684

71,656

146,787

147,141

CASH FLOWS FROM FINANCING ACTIVITIES:

Tax withholding related to vesting of restricted share units

-

-

(1,802)

-

Repurchase of ordinary shares

(56,511)

(27,484)

(87,752)

(127,444)

Exercise of options

19

505

636

999

Net cash used in financing activities

(56,492)

(26,979)

(88,918)

(126,445)

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH

EQUIVALENTS

(365)

1,540

(676)

2,096

NET INCREASE IN CASH AND CASH EQUIVALENTS

1,878

70,289

93,630

60,908

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

394,295

145,948

302,543

155,329

CASH AND CASH EQUIVALENTS AT END OF PERIOD

396,173

216,237

396,173

216,237

INMODE LTD.

CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS

(U.S. dollars in thousands, except for per share data)

(Unaudited)

Three months ended June 30,

Six months ended June 30,

2026

2025

2026

2025

Revenues by Category:

Capital Equipment revenues - United States

43,084

45 %

40,653

42 %

76,753

43 %

70,195

40 %

Capital Equipment revenues - International

30,194

32 %

35,133

37 %

57,179

32 %

63,266

37 %

Total Capital Equipment revenues

73,278

77 %

75,786

79 %

133,932

75 %

133,461

77 %

Consumables and service revenues

22,311

23 %

19,816

21 %

43,674

25 %

40,015

23 %

Total Revenue

95,589

100 %

95,602

100 %

177,606

100 %

173,476

100 %

Three months ended June 30,

Six months ended June 30,

2026

2025

2026

2025

%

%

%

%

United States

International

Total

United States

International

Total

United States

International

Total

United States

International

Total

Revenues by Technology:

Minimal-Invasive

71

73

73

73

82

78

73

77

75

82

81

81

Hands-Free

1

2

1

4

2

3

1

1

1

3

2

3

Non-Invasive

28

25

26

23

16

19

26

22

24

15

17

16

100

100

100

100

100

100

100

100

100

100

100

100

INMODE LTD.

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF

INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME 

(U.S. dollars in thousands, except for per share data)

(Unaudited)

Three months ended June 30, 2026

Three months ended June 30, 2025

GAAP 

Stock Based

Compensation

Non-GAAP

GAAP 

Stock Based

Compensation

Non-GAAP

REVENUES

95,589



95,589

95,602



95,602

COST OF REVENUES

24,073

(302)

23,771

19,152

(334)

18,818

GROSS PROFIT

71,516

302

71,818

76,450

334

76,784

OPERATING EXPENSES:

Research and development

3,656

(282)

3,374

3,372

(287)

3,085

Sales and marketing

50,818

(2,525)

48,293

47,474

(2,529)

44,945

General and administrative

4,785

(599)

4,186

2,723

(268)

2,455

TOTAL OPERATING EXPENSES

59,259

(3,406)

55,853

53,569

(3,084)

50,485

OPERATING INCOME

12,257

3,708

15,965

22,881

3,418

26,299

Finance income, net

7,432



7,432

8,062

-

8,062

INCOME BEFORE INCOME TAXES

19,689

3,708

23,397

30,943

3,418

34,361

INCOME TAXES

2,625

(40)

2,585

4,201

21

4,222

NET INCOME

17,064

3,748

20,812

26,742

3,397

30,139

EARNINGS PER SHARE

Basic

0.29

0.35

0.42

0.48

Diluted

0.29

0.35

0.42

0.47

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN
COMPUTATION OF NET INCOME PER SHARE (in Thousands)

Basic

58,903

58,903

63,252

63,252

Diluted

59,378

60,174

63,637

64,537

Six months ended June 30, 2026

Six months ended June 30, 2025

GAAP

Stock Based Compensation

Expenses 
Related to
Independent
Transaction
Committee 
Review

Non-GAAP

GAAP

Stock Based Compensation

Non-GAAP

REVENUES

177,606





177,606

173,476

-

173,476

COST OF REVENUES

44,538

(616)



43,922

36,115

(644)

35,471

GROSS PROFIT

133,068

616



133,684

137,361

644

138,005

OPERATING EXPENSES:

Research and development

7,198

(550)



6,648

6,267

(509)

5,758

Sales and marketing

93,750

(4,386)



89,364

87,201

(4,292)

82,909

General and administrative

9,807

(855)

(1,262)

7,690

5,394

(491)

4,903

TOTAL OPERATING EXPENSES

110,755

(5,791)

(1,262)

103,702

98,862

(5,292)

93,570

OPERATING INCOME

22,313

6,407

1,262

29,982

38,499

5,936

44,435

Finance income, net

11,728





11,728

14,921

-

14,921

INCOME BEFORE INCOME TAXES

34,041

6,407

1,262

41,710

53,420

5,936

59,356

INCOME TAXES

5,415

(389)



5,026

8,477

(655)

7,822

NET INCOME

28,626

6,796

1,262

36,684

44,943

6,591

51,534

EARNINGS PER SHARE

Basic

0.47

0.60

0.68

0.78

Diluted

0.46

0.59

0.68

0.77

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in Thousands)

Basic

61,140

61,140

65,982

65,982

Diluted

61,717

62,324

66,540

67,052

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

SOURCE InMode Ltd.
2026-07-13 13:08 1mo ago
2026-07-13 07:00 1mo ago
InMode potvrdila výhled na tržby pro rok 2026
INMD InMode
FMP Stock News 78
Original source text
, /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the second quarter of 2026 before the Nasdaq market opens on Wednesday, August 5, 2026.

InMode is currently finalizing its financial results for the second quarter of 2026. While complete financial information and operating data are not yet available, set forth below are certain preliminary results such period, subject to final adjustments and other developments that may arise between now and the time such financial results are finalized. Based on preliminary results, management expects:

Revenue for the second quarter of 2026 to be in the range of $95.2 million to $95.4 million Full year 2026 revenue to be in the range of $365 million to $375 million As the Company's Special Committee continues its evaluation of strategic proposals, the Company will not host an investor conference call or webcast in connection with this earnings release and will not be conducting investor meetings at this time.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements 

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

SOURCE InMode Ltd.
2026-07-10 13:10 1mo ago
2026-07-10 07:00 1mo ago
InMode dostala nevyžádanou akviziční nabídku od Steel Partners
INMD InMode
FMP Stock News 78
Original source text
, /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) (the "Company") confirmed that its Board of Directors (the "Board") has received the unsolicited letter and acquisition proposal from Steel Partners Holdings L.P. dated July 9, 2026.

The Special Committee comprised solely of the independent directors of the Board (the "Special Committee"), together with its legal and financial advisors, will carefully review the proposal consistent with its fiduciary duties.

The Special Committee remains committed to acting in the best interests of all shareholders. The Special Committee does not intend to comment further at this time.

About InMode Ltd.

The Company is a leading global provider of innovative medical technologies. The Company develops, manufactures and markets devices harnessing novel radiofrequency ("RF") technology. The Company strives to enable new emerging surgical procedures as well as improve existing treatments. The Company has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. For more information about the Company and its wide array of medical technologies, visit www.inmodemd.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. In some cases, forward-looking statements can be identified by terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "will," "would" or the negative of those terms or other comparable terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding the Proposal, the special committee's review and evaluation of the Proposal, the potential consummation of any transaction and the Company's future plans, objectives, expectations and intentions. These statements involve known and unknown risks, uncertainties, and other factors that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied. Such factors include, among others: uncertainties as to whether the special committee will determine that the Proposal or any alternative transaction is in the best interests of the Company and its shareholders; the risk that the Proposal may be withdrawn or modified; the possibility that competing offers or alternatives may or may not emerge; the risk that any transaction may not be consummated on the terms or timeline currently contemplated, or at all; and the other risks described in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise except as required by law.

Contacts

Miri Segal-Scharia
MS-IR LLC
[email protected]

Logo: https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

SOURCE InMode Ltd.
2026-06-26 13:47 2mo ago
2026-06-26 08:25 2mo ago
DOMA odmítá nabídku na odkup InMode
INMD InMode
FMP Stock News 78
Original source text
DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual) DOMA ASSERTS THAT THE $16.20 PER SHARE OFFER MATERIALLY UNDERVALUES INMODE AND ITS LONG-TERM POTENTIAL

DOMA BELIEVES THE BID EXPLOITS THE DEPRESSED VALUATIONS CREATED BY YEARS OF CEO-LED UNDERPERFORMANCE

DOMA EXPLICITLY REJECTS THE CURRENT TERMS AND URGES THE BOARD TO UPLHOLD ITS FIDUCIARY DUTIES

, /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board").

The letter can be downloaded here

The full text of the letter follows:

June 26, 2026

To the Board Member of InMode:

As of the date of this letter, DOMA Perpetual Capital Management LLC ("DOMA") and its affiliates beneficially own approximately 4.63% of the outstanding ordinary shares of InMode Ltd. ("InMode" or the "Company").

We are writing as a concerned shareholder regarding the recently proposed acquisition of the Company led by the Chief Executive Officer in partnership with a group of investors. The circumstances surrounding this proposal raise serious concerns about conflicts of interest, governance, the Board's fiduciary responsibilities, and the fairness of the proposed transaction.

We believe the proposal materially undervalues the Company, particularly in light of its long-term potential and intrinsic assets. It is difficult to ignore that this proposal also follows a long period of operational underperformance under the current CEO's leadership. We have previously asked the Board, in a public communication dated May 9, 2025, to replace the CEO precisely because of his sustained underperformance, and that same CEO now appears positioned to benefit from the proposed transaction.1 In our view, these circumstances warrant close scrutiny, and DOMA reserves all of its rights in connection with the proposed transaction.

We strongly believe the proposal would allow management to capitalize on a depressed valuation that developed during its own stewardship and that, in our view, management's performance helped create. Such dynamics are deeply troubling from a governance perspective.

The Board has fiduciary obligations to act in the best interests of all shareholders, not management or any specific investor group. In this context, we urge the Board to take the following actions:

Establish a fully independent special committee with no ties to management to evaluate the proposal. Retain international independent financial and legal advisors to conduct a rigorous valuation and fairness assessment. Conduct a broad and transparent market check inviting public offers to determine whether superior offers exist. Ensure that shareholders are provided with full and fair disclosure regarding the process, assumptions, and any potential conflicts of interest. Any transaction that allows insiders to acquire the Company at a price influenced by their own stewardship must be subject to the highest level of scrutiny. Failure to do so could expose the Company and the Board to significant shareholder value destruction, as well as reputational and legal risk.

Shareholders rely on the Board to uphold strong governance standards and to protect against precisely this type of conflicted transaction. I trust that you will take these responsibilities seriously and act accordingly.

At the current offer of $16.20/share DOMA does not support the proposal and intends to vote against the transaction.

Sincerely,

Pedro Escudero
CEO & CIO
DOMA Perpetual Capital Management LLC

This letter has been prepared by DOMA. The views expressed herein reflect DOMA's opinions and are based on publicly available information regarding the Company. DOMA recognizes that the Company or others may have information not available to DOMA that could lead them to disagree with DOMA's views or conclusions. DOMA reserves the right to change or modify its views, opinions, intentions, or positions at any time and for any reason, and disclaims any obligation to update or revise the information contained herein, except as may be required by applicable law.

This letter was not prepared by, and has not been endorsed by, InMode Ltd. This letter is provided for informational purposes only and is not intended to be, and should not be construed as, an offer to sell or a solicitation of an offer to buy any security, or as a recommendation to purchase or sell any security. DOMA is not currently soliciting proxies, consents, authorizations, or voting commitments with respect to any securities of the Company. One or more funds managed by DOMA currently beneficially own shares of the Company.

Certain statements in this letter may constitute forward-looking statements. These statements reflect DOMA's current views and expectations, speak only as of the date hereof, and are subject to risks, uncertainties, and assumptions that could cause actual results or developments to differ materially from those expressed or implied.

PR Newswire, May 9, 2025, DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program (urging the Board, among other actions, to replace the Chief Executive Officer), https://www.prnewswire.com/news-releases/doma-perpetual-sends-letter-urging-board-of-directors-of-inmode-ltd-to-resume-share-repurchase-program-302451097.html SOURCE DOMA Perpetual
2026-06-24 15:56 2mo ago
2026-06-24 08:40 2mo ago
InMode potvrdila nabídku převzetí za 16,20 USD na akcii
INMD InMode
FMP Stock News 78
Original source text
, /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) (the "Company") today announced that, on June 17, 2026, its Board of Directors (the "Board") received an unsolicited  proposal from M.N. Business Strategy, Ltd. ("MN Business Strategy") to acquire through a merger all of the outstanding ordinary shares of the Company not already owned by MN Business Strategy and its affiliates for $16.20 per share in cash (the "Proposal").  MN Business Strategy is a group that includes, among others, Moshe Mizrahy, the Company's co-founder and Chief Executive Officer. 

The Board has approved formation of a special committee comprised solely of independent directors to evaluate the Proposal.  The special committee will, in consultation with its advisors, evaluate the Proposal in accordance with its fiduciary duties and the best interests of the Company and all of its shareholders.  There can be no assurance as to whether this evaluation will result in a transaction or any other strategic outcome for the Company, or as to the timing or terms of any such transaction or outcome. The Company does not intend to comment further on the special committee process or provide additional updates unless and until required to do so under applicable law or regulation.

About InMode Ltd.

The Company is a leading global provider of innovative medical technologies.  The Company develops, manufactures and markets devices harnessing novel radiofrequency ("RF") technology.  The Company strives to enable new emerging surgical procedures as well as improve existing treatments.  The Company has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology.  For more information about the Company and its wide array of medical technologies, visit www.inmodemd.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements include all statements that are not historical facts.  In some cases, forward-looking statements can be identified by terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "will," "would" or the negative of those terms or other comparable terminology.  Forward-looking statements in this press release include, but are not limited to, statements regarding the Proposal, the special committee's review and evaluation of the Proposal, the potential consummation of any transaction and the Company's future plans, objectives, expectations and intentions.  These statements involve known and unknown risks, uncertainties, and other factors that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied.  Such factors include, among others: uncertainties as to whether the special committee will determine that the Proposal or any alternative transaction is in the best interests of the Company and its shareholders; the risk that the Proposal may be withdrawn or modified; the possibility that competing offers or alternatives may or may not emerge; the risk that any transaction may not be consummated on the terms or timeline currently contemplated, or at all; and the other risks described in the Company's filings with the U.S. Securities and Exchange Commission.  The Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise except as required by law.

Contacts

Miri Segal-Scharia
MS-IR LLC
[email protected]

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

SOURCE InMode LTD